Literature DB >> 17848701

Abdominal MR imaging at 3.0 T.

Fatih M Akisik1, Kumaresan Sandrasegaran, Alex M Aisen, Chen Lin, Chandana Lall.   

Abstract

Magnetic resonance (MR) imaging at 3.0 T offers an improved signal-to-noise ratio compared with that at 1.5 T. However, the physics of high field strength also brings disadvantages, such as increases in the specific absorption rate, in magnetic field inhomogeneity effects, and in susceptibility artifacts. The use of 3.0-T MR imaging for abdominal evaluations, in particular, has lagged behind that for other applications because of the difficulty of imaging a large volume while compensating for respiratory motion. At a minimum, abdominal MR imaging at 3.0 T requires modifications in the pulse sequences used at 1.5 T. Such modifications may include a decrease in the flip angle used for refocusing pulses and an increase in the repetition time for T1-weighted acquisitions. In addition, parallel imaging and other techniques (hyper-echo sequences, transition between pseudo steady states) may be used to maintain a high signal-to-noise ratio while decreasing acquisition time and minimizing the occurrence of artifacts on abdominal MR images. (c) RSNA, 2007.

Mesh:

Year:  2007        PMID: 17848701     DOI: 10.1148/rg.275075023

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  17 in total

1.  Small (≤ 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT.

Authors:  J Hwang; S H Kim; M W Lee; J Y Lee
Journal:  Br J Radiol       Date:  2011-12-13       Impact factor: 3.039

2.  Comparison of 3 T MRI and CT for the measurement of visceral and subcutaneous adipose tissue in humans.

Authors:  B J Klopfenstein; M S Kim; C M Krisky; J Szumowski; W D Rooney; J Q Purnell
Journal:  Br J Radiol       Date:  2012-04-18       Impact factor: 3.039

3.  Renal imaging at 7 Tesla: preliminary results.

Authors:  Lale Umutlu; Stephan Orzada; Sonja Kinner; Stefan Maderwald; Irina Brote; Andreas K Bitz; Oliver Kraff; Susanne C Ladd; Gerald Antoch; Mark E Ladd; Harald H Quick; Thomas C Lauenstein
Journal:  Eur Radiol       Date:  2010-09-25       Impact factor: 5.315

4.  3.0 Tesla magnetic resonance imaging: A new standard in liver imaging?

Authors:  Rossano Girometti
Journal:  World J Hepatol       Date:  2015-07-28

5.  Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancer.

Authors:  Huaijun Wang; Guy Marchal; Yicheng Ni
Journal:  World J Radiol       Date:  2011-01-28

6.  Newly developed surface coil for endoluminal MRI, depiction of pig gastric wall layers and vascular architecture in ex vivo study.

Authors:  Yoshinori Morita; Hiromu Kutsumi; Hayato Yoshinaka; Yuichiro Matsuoka; Kagayaki Kuroda; Masakazu Gotanda; Naomi Sekino; Etsuko Kumamoto; Masaru Yoshida; Hideto Inokuchi; Takeshi Azuma
Journal:  J Gastroenterol       Date:  2009-03-17       Impact factor: 7.527

7.  Gd-EOB-DTPA-enhanced 3.0 T MR imaging: quantitative and qualitative comparison of hepatocyte-phase images obtained 10 min and 20 min after injection for the detection of liver metastases from colorectal carcinoma.

Authors:  Keitaro Sofue; Masakatsu Tsurusaki; Hiroyuki Tokue; Yasuaki Arai; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2011-07-12       Impact factor: 5.315

8.  Detection of hepatic metastases by superparamagnetic iron oxide-enhanced MR imaging: prospective comparison between 1.5-T and 3.0-T images in the same patients.

Authors:  Keitaro Sofue; Masakatsu Tsurusaki; Mototaka Miyake; Aine Sakurada; Yasuaki Arai; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2010-04-29       Impact factor: 5.315

Review 9.  Advanced MR Imaging of the Pancreas.

Authors:  Danielle V Hill; Temel Tirkes
Journal:  Magn Reson Imaging Clin N Am       Date:  2020-06-03       Impact factor: 2.266

10.  Parenchymal signal intensity in 3-T body MRI of dogs with hematopoietic neoplasia.

Authors:  Daniel A Feeney; Leslie C Sharkey; Susan M Steward; Katherine L Bahr; Michael S Henson; Daisuke Ito; Timothy D O'Brien; Carl R Jessen; Brian D Husbands; Antonella Borgatti; Jaime F Modiano
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.